By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biolipox AB 

P.O. Box 6280
Västmannagatan 15
Stockholm    SE-102 34   Sweden
Phone: 46-0-8-545-281-40 Fax: 46-0-8-545-281-41



Company News
Inflazyme Pharmaceuticals Ltd. (IZP.TO) Announces Closing of Transaction With Biolipox AB 11/20/2007 4:16:34 PM
Inflazyme Pharmaceuticals Ltd. (IZP.TO): Orexo AB Shareholders Approve Acquisition of Biolipox AB 11/14/2007 9:22:00 AM
Orexo AB Acquires Biolipox AB 11/12/2007 2:58:19 PM
Orexo AB to Acquire Biolipox AB 10/26/2007 11:36:13 AM
Orexo AB to Acquire Biolipox AB - Building a Specialty Pharma Company Driven by Innovation; SEK 856 Million 10/15/2007 12:41:44 PM
Inflazyme Pharmaceuticals Ltd. (IZP.TO) Signs Asset Sale Agreement With Biolipox AB for a Potential Value of up to $11 Million, Plus a Potential Royalty Payment 9/24/2007 9:00:12 AM
Biolipox AB Reports Rapid Relief With NLA Nasal Spray In New Clinical Trial10/19/2005 5:12:48 PM
NicOx SA (NCOX.F) NCX 1510 Partnered With Biolipox AB Demonstrates Rapid Relief In New Clinical Trial10/19/2005 5:12:47 PM
Biolipox AB Raises $41 Million To Advance Preclinical Inflammation Programs10/19/2005 5:12:12 PM
First NicOx SA (FR:N07413) Compound In Biolipox AB Collaboration Enters Phase II10/19/2005 5:09:44 PM